CoChat

Palmitoylethanolamide normalizes intestinal motility in a model of post‐inflammatory accelerated transit: involvement of CB1 receptors and TRPV 1 channels

Open access
Capasso, Raffaele, Orlando, Pierangelo, Pagano, Ester, Aveta, Teresa, Buono, Lorena, Borrelli, Francesca, Di Marzo, Vincenzo, Izzo, Angelo A · 2014 · British Journal of Pharmacology
Cited by 84

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Palmitoylethanolamide (PEA), a naturally occurring acylethanolamide chemically related to the endocannabinoid anandamide, interacts with targets that have been identified in peripheral nerves controlling gastrointestinal motility, such as cannabinoid CB1 and CB2 receptors, TRPV 1 channels and PPAR α. Here, we investigated the effect of PEA in a mouse model of functional accelerated transit which persists after the resolution of colonic inflammation (post‐inflammatory irritable bowel syndrome). Experimental Approach: Intestinal inflammation was induced by intracolonic administration of oil of mustard (OM). Mice were tested for motility and biochemical and molecular biology changes 4 weeks later. PEA, oleoylethanolamide and endocannabinoid levels were measured by liquid chromatography‐mass spectrometry and receptor and enzyme mRNA expression by qRT‐PCR. Key Results: OM induced transient colitis and a functional post‐inflammatory increase in upper gastrointestinal transit, associated with increased intestinal anandamide (but not 2‐arachidonoylglycerol, PEA or oleoylethanolamide) levels and down‐regulation of mRNA for TRPV 1 channels. Exogenous PEA inhibited the OM‐induced increase in transit and tended to increase anandamide levels. Palmitic acid had a weaker effect on transit. Inhibition of transit by PEA was blocked by rimonabant (CB1 receptor antagonist), further increased by 5′‐iodoresiniferatoxin (TRPV1 antagonist) and not significantly modified by the PPAR α antagonist GW 6471. Conclusions and Implications: Intestinal endocannabinoids and TRPV 1 channel were dysregulated in a functional model of accelerated transit exhibiting aspects of post‐inflammatory irritable bowel syndrome. PEA counteracted the accelerated transit, the effect being mediated by CB1 receptors (possibly via increased anandamide levels) and modulated by TRPV 1 channels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12759

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 84

Metadata

Authors
Capasso, R., Orlando, P., Pagano, E., Aveta, T., Buono, L., Borrelli, F., Di Marzo, V., & Izzo, A. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2014-08-12
Volume
171
Issue
17
Pages
4026-4037
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1545487830
Cited by
84
References
7
FWCI
7.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Palmitoylethanolamide normalizes intestinal motility in a model of post‐inflammatory accelerated transit: involvement of CB1 receptors and TRPV 1 channels. https://app.cochat.ai/papers/10.1111/bph.12759
The paper
Capasso, R., Orlando, P., Pagano, E., Aveta, T., Buono, L., Borrelli, F., Di Marzo, V., & Izzo, A. A. (2014). Palmitoylethanolamide normalizes intestinal motility in a model of post‐inflammatory accelerated transit: involvement of CB1 receptors and TRPV 1 channels. British Journal of Pharmacology. https://doi.org/10.1111/bph.12759

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.